8 datasets found
  1. k

    ERAS Stock Forecast Data

    • kappasignal.com
    csv, json
    Updated Apr 25, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    AC Investment Research (2024). ERAS Stock Forecast Data [Dataset]. https://www.kappasignal.com/2024/04/erasca-ascending-will-eras-outperform.html
    Explore at:
    json, csvAvailable download formats
    Dataset updated
    Apr 25, 2024
    Dataset authored and provided by
    AC Investment Research
    License

    https://www.ademcetinkaya.com/p/legal-disclaimer.htmlhttps://www.ademcetinkaya.com/p/legal-disclaimer.html

    Description

    Erasca stock has high potential for growth, supported by positive analyst estimates and strong financial performance. However, consider the company's dependence on a single drug in development, which poses a risk to revenue stability.

  2. Worldwide box office revenue of "Taylor Swift: The Eras Tour" 2024, by...

    • statista.com
    Updated May 16, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Worldwide box office revenue of "Taylor Swift: The Eras Tour" 2024, by region [Dataset]. https://www.statista.com/statistics/1418743/box-office-revenue-taylor-swift-eras-tour-concert-movie-region-worlwide/
    Explore at:
    Dataset updated
    May 16, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Canada, United States, Worldwide
    Description

    As of April 5, 2024, the concert movie “Taylor Swift: The Eras Tour” garnered around 262 million U.S. dollars worldwide and about 181 million dollars domestically during its release weekend. "The Eras Tour" is holding first place as the highest-grossing concert movie ever made, followed by "Justin Bieber: Never Say Never", released in 2011.

  3. A leading UK provider of product discounts for online shoppers wanted to...

    • globaldata.com
    Updated Oct 24, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    GlobalData UK Ltd. (2024). A leading UK provider of product discounts for online shoppers wanted to forecast predicted consumer spending, and shopping trends across the UK leg of Taylor Swift’s Eras tour in 2024 [Dataset]. https://www.globaldata.com/custom-solutions/solutions-in-action/leading-uk-provider-product-discounts-online-shoppers-wanted-forecast-predicted-consumer-spending-shopping-trends-across-uk-leg-taylor-swifts-eras-tour-2024/
    Explore at:
    Dataset updated
    Oct 24, 2024
    Dataset provided by
    GlobalDatahttps://www.globaldata.com/
    Authors
    GlobalData UK Ltd.
    License

    https://www.globaldata.com/privacy-policy/https://www.globaldata.com/privacy-policy/

    Area covered
    United Kingdom, Global
    Description
  4. w

    Dataset of highest price of stocks over time for ERAS and after 2024-09-12

    • workwithdata.com
    Updated May 6, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Work With Data (2025). Dataset of highest price of stocks over time for ERAS and after 2024-09-12 [Dataset]. https://www.workwithdata.com/datasets/stocks-daily?col=date%2Chighest_price%2Cstock&f=2&fcol0=stock&fcol1=date&fop0=%3D&fop1=%3E&fval0=ERAS&fval1=2024-09-12
    Explore at:
    Dataset updated
    May 6, 2025
    Dataset authored and provided by
    Work With Data
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    This dataset is about stocks per day. It has 160 rows and is filtered where the stock is ERAS and the date is after the 12th of September 2024. It features 3 columns: stock, and highest price.

  5. Z

    Pulmonary Arterial Hypertension Treatment Market By Drug Class (Prostacyclin...

    • zionmarketresearch.com
    pdf
    Updated Aug 14, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Zion Market Research (2025). Pulmonary Arterial Hypertension Treatment Market By Drug Class (Prostacyclin & Prostacyclin Analogs, Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, and SGC Stimulators), By Type (Generic and Branded), By Route of Administration (Intravenous/Subcutaneous, Oral, and Inhalational), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032 [Dataset]. https://www.zionmarketresearch.com/report/pulmonary-arterial-hypertension-treatment-market
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Aug 14, 2025
    Dataset authored and provided by
    Zion Market Research
    License

    https://www.zionmarketresearch.com/privacy-policyhttps://www.zionmarketresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    Global pulmonary arterial hypertension treatment market size being evaluated $7.88 B in 2023 and is expected to hit to $12.76 B by 2032 at a CAGR of 5.5%.

  6. Erasca Ascending: Will ERAS Outperform? (Forecast)

    • kappasignal.com
    Updated Apr 25, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    KappaSignal (2024). Erasca Ascending: Will ERAS Outperform? (Forecast) [Dataset]. https://www.kappasignal.com/2024/04/erasca-ascending-will-eras-outperform.html
    Explore at:
    Dataset updated
    Apr 25, 2024
    Dataset authored and provided by
    KappaSignal
    License

    https://www.kappasignal.com/p/legal-disclaimer.htmlhttps://www.kappasignal.com/p/legal-disclaimer.html

    Description

    This analysis presents a rigorous exploration of financial data, incorporating a diverse range of statistical features. By providing a robust foundation, it facilitates advanced research and innovative modeling techniques within the field of finance.

    Erasca Ascending: Will ERAS Outperform?

    Financial data:

    • Historical daily stock prices (open, high, low, close, volume)

    • Fundamental data (e.g., market capitalization, price to earnings P/E ratio, dividend yield, earnings per share EPS, price to earnings growth, debt-to-equity ratio, price-to-book ratio, current ratio, free cash flow, projected earnings growth, return on equity, dividend payout ratio, price to sales ratio, credit rating)

    • Technical indicators (e.g., moving averages, RSI, MACD, average directional index, aroon oscillator, stochastic oscillator, on-balance volume, accumulation/distribution A/D line, parabolic SAR indicator, bollinger bands indicators, fibonacci, williams percent range, commodity channel index)

    Machine learning features:

    • Feature engineering based on financial data and technical indicators

    • Sentiment analysis data from social media and news articles

    • Macroeconomic data (e.g., GDP, unemployment rate, interest rates, consumer spending, building permits, consumer confidence, inflation, producer price index, money supply, home sales, retail sales, bond yields)

    Potential Applications:

    • Stock price prediction

    • Portfolio optimization

    • Algorithmic trading

    • Market sentiment analysis

    • Risk management

    Use Cases:

    • Researchers investigating the effectiveness of machine learning in stock market prediction

    • Analysts developing quantitative trading Buy/Sell strategies

    • Individuals interested in building their own stock market prediction models

    • Students learning about machine learning and financial applications

    Additional Notes:

    • The dataset may include different levels of granularity (e.g., daily, hourly)

    • Data cleaning and preprocessing are essential before model training

    • Regular updates are recommended to maintain the accuracy and relevance of the data

  7. w

    Dataset of opening price of stocks over time for ERAS and after 2024-09-07

    • workwithdata.com
    Updated May 6, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Work With Data (2025). Dataset of opening price of stocks over time for ERAS and after 2024-09-07 [Dataset]. https://www.workwithdata.com/datasets/stocks-daily?col=date%2Copening_price%2Cstock&f=2&fcol0=stock&fcol1=date&fop0=%3D&fop1=%3E&fval0=ERAS&fval1=2024-09-07
    Explore at:
    Dataset updated
    May 6, 2025
    Dataset authored and provided by
    Work With Data
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    This dataset is about stocks per day. It has 164 rows and is filtered where the stock is ERAS and the date is after the 7th of September 2024. It features 3 columns: stock, and opening price.

  8. s

    Worldwide box office revenue of concert movies as of April 2024

    • statista.com
    Updated Jun 24, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Worldwide box office revenue of concert movies as of April 2024 [Dataset]. https://www.statista.com/statistics/1411689/highest-grossing-concert-movies-box-office-revenue-worldwide/
    Explore at:
    Dataset updated
    Jun 24, 2025
    Dataset authored and provided by
    Statista
    Area covered
    Worldwide
    Description

    As of October 2024, "Taylor Swift: The Eras Tour" was the highest grossing concert movie released in theaters with a total global revenue of ****** million U.S. dollars. It surpasses "Justin Bieber: Never Say Never", released in 2011, currently in second position with a total box office revenue of ** million U.S. dollars. A new era for Taylor Swift Following the footsteps of Taylor Swift’s highly successful ongoing tour, "Taylor Swift: The Eras Tour" is a box office sensation. As of April 2024, the most recent data showed that around 70 percent of the film's box office revenue was generated in the United States and Canada alone. Taylor Swift's concert film managed to climb to eighth place in the year's highest grossing movie weekends, behind heavy hitters such as “Barbie” and “The Super Mario Bros. Movie”. Swift not only has a large and loyal fanbase, but is now a household name - in 2023, three quarters of Americans were very or somewhat familiar with her work. Rethinking the movie experience The year 2023 turned out to be a mixed bag for the world of cinema. While attendance and box office figures are generally on the rise following the decrease recorded in 2020, these values have struggled to reach pre-pandemic levels. The success of the “Barbenheimer” phenomenon is nevertheless an indication that audiences are still ready to flock to cinemas for films which are set to become major events. Moreover, the release of several concert films such as “Taylor Swift: The Eras Tour” and "Renaissance: A Film by Beyoncé" is proof that cinema has the capacity to achieve a wider cultural impact beyond feature films.

  9. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
AC Investment Research (2024). ERAS Stock Forecast Data [Dataset]. https://www.kappasignal.com/2024/04/erasca-ascending-will-eras-outperform.html

ERAS Stock Forecast Data

Explore at:
json, csvAvailable download formats
Dataset updated
Apr 25, 2024
Dataset authored and provided by
AC Investment Research
License

https://www.ademcetinkaya.com/p/legal-disclaimer.htmlhttps://www.ademcetinkaya.com/p/legal-disclaimer.html

Description

Erasca stock has high potential for growth, supported by positive analyst estimates and strong financial performance. However, consider the company's dependence on a single drug in development, which poses a risk to revenue stability.

Search
Clear search
Close search
Google apps
Main menu